Uptravi vs. Tyvaso

Reviewed on 8/20/2020

Are Uptravi and Tyvaso the Same Thing?

Uptravi (selexipag) and Tyvaso (treprostinil) are used to treat pulmonary arterial hypertension.

Uptravi and Tyvaso belong to different drug classes. Uptravi is a prostacyclin receptor agonist and Tyvaso is a vasodilator.

Side effects of Uptravi and Tyvaso that are similar include headache, diarrhea, jaw pain, nausea, muscle pain, and flushing (warmth, redness, or tingly feeling).

Side effects of Uptravi that are different from Tyvaso include vomiting, pain in extremities, joint pain, low levels of iron in the blood (anemia), decreased appetite, and rash.

Side effects of Tyvaso that are different from Uptravi include cough, sore throat, throat irritation or pain after use, dizziness, and bone pain.

Both Uptravi and Tyvaso may interact with gemfibrozil.

Uptravi may also interact with teriflunomide, deferasirox, and rifampin.

Tyvaso may also interact with delavirdine, nicardipine, pioglitazone, tolbutamide, antibiotics, antifungals, blood pressure medications, blood thinners, diuretics, medications to treat congestive heart failure, nonsteroidal anti-inflammatory drugs (NSAIDs), seizure medications, and sulfa drugs.

What Are Possible Side Effects of Uptravi?

Common side effects of Uptravi include:

Side effects of Uptravi include:

  • headache,
  • diarrhea,
  • jaw pain,
  • nausea,
  • muscle pain,
  • vomiting,
  • pain in extremities,
  • flushing (warmth, redness, or tingly feeling),
  • joint pain,
  • low levels of iron in the blood (anemia),
  • decreased appetite, or
  • rash

What Are Possible Side Effects of Tyvaso?

Common side effects of Tyvaso include:

  • cough
  • headache
  • sore throat
  • throat irritation or pain after use
  • nausea
  • flushing
  • dizziness
  • diarrhea
  • jaw/muscle/bone pain
  • flushing (warmth, redness, or tingling)

Fainting is another common side effect of Tyvaso. If fainting occurs after taking Tyvaso, get medical help right away.

QUESTION

COPD (chronic obstructive pulmonary disease) is the same as adult-onset asthma. See Answer

What Is Uptravi?

Uptravi (selexipag) is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.

What Is Tyvaso?

Tyvaso (treprostinil) Inhalation Solution is a vasodilator used to treat pulmonary arterial hypertension (PAH). Tyvaso improves your ability to exercise and prevents your condition from getting worse.

What Drugs Interact With Uptravi?

Uptravi may interact with strong inhibitors of CYP2C8 (e.g., gemfibrozil). Tell your doctor all medications and supplements you use.

What Drugs Interact With Tyvaso?

Tyvaso may interact with gemfibrozil, delavirdine, nicardipine, pioglitazone, tolbutamide, antibiotics, antifungals, blood pressure medications, blood thinners, diuretics, medications to treat congestive heart failure, NSAIDs (non-steroidal anti-inflammatory drugs), seizure medications, or sulfa drugs. Tell your doctor all medications and supplements you use.

How Should Uptravi be Taken?

The starting dose of Uptravi is 200 mcg twice daily. Increase the dose of Uptravi by 200 mcg twice daily at weekly intervals to the highest tolerated dose up to 1600 mcg twice daily.

How Should Tyvaso be Taken?

The initial adult dosage of Tyvaso therapy should begin with 3 breaths of Tyvaso (18 mcg of treprostinil), per treatment session, 4 times daily. If 3 breaths are not tolerated, reduce to 1 or 2 breaths and subsequently increase to 3 breaths, as tolerated.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Actelion Pharmaceuticals Ltd. Uptravi Product Information.

www.uptravi.com/

United Therapeutics Corporation. Tyvaso Product Informtion

https://www.tyvaso.com/

Health Solutions From Our Sponsors